Immune Design Corp. (NASDAQ:IMDZ) Basic Net EPS Stands At $-2.06

0

Immune Design Corp. (NASDAQ:IMDZ) had an annual basic consolidated EPS of $-2.0591 for the period ended 2015-12-31. For the quarter ended 2015-12-31 which was on quarterly basis, the basic consolidated EPS reading was $-2.0591.

EPS from continuing operations

Immune Design Corp. (NASDAQ:IMDZ) reported $-2.0591 as the basic EPS from continuing operations for the annual period ended 2015-12-31. Quarterly basic EPS from continuing operations stood at $-2.0591 for the three-month period ended 2015-12-31.

EPS contribution from parent

From its parent company, Immune Design Corp. (NASDAQ:IMDZ) received basic EPS of $-2.0591 for the annual period ended 2015-12-31. EPS contribution from the parent company was $-2.0591 which was on quarterly basis for the period ended 2015-12-31.

Basic net EPS

A basic net EPS of $-2.06 was reported by Immune Design Corp. (NASDAQ:IMDZ) for the annual period ended 2015-12-31. For the three-month period ended 2015-12-31 which was on a quarterly basis, the company’s basic net EPS stood at $-2.06.

Consolidated diluted EPS

For the period ended 2015-12-31, $-2.0591 was reported as the annual consolidated diluted EPS reading. Consolidated diluted EPS was $-2.0591 for the quarter ended 2015-12-31.

Basic diluted EPS

Diluted EPS reading from continuing operation was $-2.0591 which was on annual basis but for the period ended 2015-12-31. From continuing operations, Diluted EPS was $-2.0591 for the quarter ended 2015-12-31.

Net diluted EPS

Net diluted EPS reading was $-2.06 for the annual period ended 2015-12-31 while the net diluted EPS for the quarterly period ended 2015-12-31 stood at $-2.06.

Diluted EPS from parent

Diluted EPS of $-2.0591 was received by Immune Design Corp. (NASDAQ:IMDZ) from its parent company which was for the annual period ended 2015-12-31. For the quarter ended 2015-12-31, diluted EPS contribution from the parent was $-2.0591 on quarterly basis. For the annual period ended 2015-12-31, $-2.06 was posted by Immune Design Corp. (NASDAQ:IMDZ) as net basic EPS reading.

For the quarter ended 2015-12-31, basic net EPS of $-2.06 was reported. The period ended 2015-12-31 had annual average basic shares outstanding of 19.156. But it was 19.156 for the quarter ended 2015-12-31. 19.156 and 19.156 were the diluted shares outstanding for the fiscal year ended is 2015-12-31 respectively.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 9 times, 1 visits today)